Article
Tumor Evolution as a Therapeutic Target
21 Jul 2017
Abstract excerpt
Abstract Recent technological advances in the field of molecular diagnostics (including blood-based tumor genotyping) allow the measurement of clonal evolution in patients with cancer, thus adding a new dimension to precision medicine: time. The translation of this new knowledge into clinical benefit implies rethinking therapeutic strategies. In essence, it means considering as a target not only individual...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
